Literature DB >> 18415654

Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: a case report and literature review.

Hiroshi I Suzuki1, Akira Hangaishi1, Noriko Hosoya1,2, Takuro Watanabe1, Yoshinobu Kanda1, Toru Motokura1, Shigeru Chiba2, Mineo Kurokawa3.   

Abstract

Neurological complications during the treatment of hematological malignancies have a wide range of causes. Treatment-related leukoencephalopathy has been recognized as a major complication of combined chemotherapy and radiotherapy for central nervous system (CNS) lymphoma, and can complicate the diagnosis of CNS infection. Herein, we present a patient with diffuse large B-cell lymphoma who developed herpes simplex encephalitis (HSE) and subsequent cytomegalovirus encephalitis after chemoradiotherapy for CNS relapse. Although cerebrospinal fluid examination (CSF) showed no significant pleocytosis, brain magnetic resonance imaging and polymerase chain reaction analysis of the CSF were useful in the diagnosis. With a review of the literature on the association between HSE and radiotherapy for CNS malignancies, our case suggests that an awareness of viral encephalitis is important in the differential diagnosis of acute neurologic disturbance during chemoradiotherapy for CNS lymphoma.

Entities:  

Mesh:

Year:  2008        PMID: 18415654     DOI: 10.1007/s12185-008-0083-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Dissociation of 99mTc-ECD and 99mTc-HMPAO distributions in herpes simplex encephalitis.

Authors:  Y Tohyama; K Sako; G Daita; Y Yonemasu; N Shuke; T Aburano
Journal:  Childs Nerv Syst       Date:  1997-06       Impact factor: 1.475

2.  FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.

Authors:  H Palmedo; H Urbach; H Bender; U Schlegel; I G H Schmidt-Wolf; A Matthies; M Linnebank; A Joe; J Bucerius; H-J Biersack; H Pels
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

3.  18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.

Authors:  Dimitrios Karantanis; Brian P O'eill; Rathan M Subramaniam; Robert J Witte; Brian P Mullan; Mark A Nathan; Val J Lowe; Patrick J Peller; Gregory A Wiseman
Journal:  Nucl Med Commun       Date:  2007-11       Impact factor: 1.690

Review 4.  Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy.

Authors:  C Oakley; J B Epstein; C H Sherlock
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-09

5.  Coinfection of the central nervous system by cytomegalovirus and herpes simplex virus type 1 or 2 in AIDS patients: autopsy study on 82 cases by immunohistochemistry and polymerase chain reaction.

Authors:  L Vago; M Nebuloni; E Sala; P Cinque; S Bonetto; A Isella; L Ottoni; A Crociati; G Costanzi
Journal:  Acta Neuropathol       Date:  1996-10       Impact factor: 17.088

6.  Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.

Authors:  Martin Kocher; Sabine Kunze; Hans-Theodor Eich; Robert Semrau; Rolf-Peter Müller
Journal:  Strahlenther Onkol       Date:  2005-03       Impact factor: 3.621

7.  Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.

Authors:  Antonello Calderoni; Stefan Aebi
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 8.  Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

Authors:  Rose Lai; Lauren E Abrey; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

9.  Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.

Authors:  Frank Saran; Brigitta G Baumert; Antonia L Creak; Alan P Warrington; Sue Ashley; Daphne Traish; Michael Brada
Journal:  Pediatr Blood Cancer       Date:  2008-03       Impact factor: 3.167

10.  A Herpes simplex virus-1 fatal encephalitis following chemo-radiotherapy, steroids and prophylactic cranial irradiation in a small cell lung cancer patient.

Authors:  G Silvano; G Lazzari; F Resta; G Buccoliero; G Pezzella; S Pisconti
Journal:  Lung Cancer       Date:  2007-03-26       Impact factor: 5.705

View more
  5 in total

1.  Herpes simplex encephalitis in patients with cancer.

Authors:  Jerome J Graber; Marc K Rosenblum; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

2.  Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy.

Authors:  Nir Hersh; Israel Steiner; Tali Siegal; Felix Benninger
Journal:  J Neurovirol       Date:  2021-09-21       Impact factor: 2.643

3.  Primary central nervous system lymphoma mimicking herpes encephalitis.

Authors:  Ifrah Zawar; Sung-Min Cho; Richard Prayson; Kerry Levin
Journal:  Neurooncol Pract       Date:  2021-08-10

4.  Neurological complication of non Hodgkin lymphoma in childhood: experience from a single center in Turkey.

Authors:  Dogan Kose; Yahya Paksoy; Yavuz Koksal; Ekrem Unal
Journal:  Childs Nerv Syst       Date:  2013-08-30       Impact factor: 1.532

5.  Double encephalitis with herpes simplex virus type II and cytomegalovirus in an elder Chinese: a case report.

Authors:  Chaobiao Xue; Shaoxian Chen; Qi Lin; Houshi Zhou; Chuming Huang; Jiyuan Lin; Weihang Xie; Kai Chen; Dongming Zhou; Wan Ma; Feiyu Ma; Haiyun Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-02       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.